Orlistat precautions
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
List of precautions
General
Urinary oxalate
Weight-loss
General
Patients should be advised to adhere to dietary guidelines. Gastrointestinal eventsmay
increase when XENICAL is taken with a diet high in fat (>30% total daily calories from
fat). The daily intake of fat should be distributed over three main meals. If XENICAL is
taken with any one meal very high in fat, the possibility of gastrointestinal effects
increases. Patients should be strongly encouraged to take a multivitamin supplement that contains
fat-soluble vitamins to ensure adequate nutrition because XENICAL has been shown to
reduce the absorption of some fat-soluble vitamins and beta-carotene. In addition, the levels of vitamin D and beta-carotene may
be low in obese patients compared with non-obese subjects. The supplement should be
taken once a day at least 2 hours before or after the administration of XENICAL, such as
at bedtime. Return to top
Urinary oxalate
Some patients may develop increased levels of urinary oxalate following treatment with
XENICAL. Caution should be exercised when prescribing XENICAL to patients with a
history of hyperoxaluria or calcium oxalate nephrolithiasis. Weight-loss induction by XENICAL may be accompanied by improved metabolic control in diabetics, which might require a reduction in dose of oral hypoglycemic medication (eg, sulfonylureas, metformin) or insulin. Return to top
Weight-loss
Weight-loss induction by XENICAL may be accompanied by improved metabolic
control in diabetics, which might require a reduction in dose of oral hypoglycemic
medication (eg, sulfonylureas, metformin) or insulin. Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

